Insider Selling: Philip A. Laskawy Sells 15,438 Shares of Henry Schein Stock (HSIC)
Henry Schein (NASDAQ:HSIC) Director Philip A. Laskawy unloaded 15,438 shares of Henry Schein stock on the open market in a transaction dated Tuesday, September 2nd. The shares were sold at an average price of $119.40, for a total transaction of $1,843,297.20. Following the completion of the transaction, the director now directly owns 17,543 shares of the company’s stock, valued at approximately $2,094,634. The sale was disclosed in a filing with the SEC, which can be accessed through this link.
Shares of Henry Schein (NASDAQ:HSIC) traded down 0.22% on Wednesday, hitting $119.54. The stock had a trading volume of 234,176 shares. Henry Schein has a 52-week low of $101.20 and a 52-week high of $120.99. The stock has a 50-day moving average of $118.2 and a 200-day moving average of $117.6. The company has a market cap of $10.141 billion and a P/E ratio of 23.07.
Henry Schein (NASDAQ:HSIC) last announced its earnings results on Monday, August 4th. The company reported $1.35 earnings per share for the quarter, beating the analysts’ consensus estimate of $1.33 by $0.02. The company had revenue of $2.60 billion for the quarter, compared to the consensus estimate of $2.56 billion. During the same quarter last year, the company posted $1.23 earnings per share. Henry Schein’s revenue was up 9.3% compared to the same quarter last year. On average, analysts predict that Henry Schein will post $5.38 earnings per share for the current fiscal year.
A number of analysts have recently weighed in on HSIC shares. Analysts at Zacks reiterated a “neutral” rating on shares of Henry Schein in a research note on Friday, August 29th. They now have a $125.00 price target on the stock. Separately, analysts at Credit Suisse reiterated a “neutral” rating on shares of Henry Schein in a research note on Tuesday, August 5th. They now have a $121.00 price target on the stock, up previously from $120.00. Finally, analysts at Leerink Swann raised their price target on shares of Henry Schein from $120.00 to $127.00 in a research note on Tuesday, August 5th. They now have a “market perform” rating on the stock. Four analysts have rated the stock with a hold rating and one has assigned a buy rating to the stock. The company presently has an average rating of “Hold” and a consensus price target of $123.60.
Henry Schein, Inc is a provider of health care products and services to office-based practitioners. The Company conducts its business through two segments: healthcare distribution and technology.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.